Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis
Status:
Recruiting
Trial end date:
2022-06-21
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the Efficacy and Safety of RPH-104 Treatment in
patients in comparison to placebo with Idiopathic Recurrent Pericarditis
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
R-Pharm International, LLC
Collaborators:
Covance Data Management 365 LLC Unimed Laboratories CJSC